TLDRocket
Sign in

AI & Healthcare

226 summarised stories about AI & Healthcare, each linking back to the original source. Browse all topics →

+ Follow this topic

Tuesday, 15 September 2026

Exclusive: Brighteye closes $72M for Fund III to back ‘HumanOS’, the layer beyond edtech

Tech Funding News 1 month ago 51 ● 2 sources

Brighteye Ventures secured a $72M first close for Fund III focused on its “HumanOS” approach beyond edtech. The fund targets €100M (about $115M) with a final close expected in the first half of 2027. The company plans to invest in up to 35 HumanOS companies with over 90% of capital in $0.5M–$4M core cheques and the rest in smaller idea-stage bets.

Startup Evvy raises $40M to accelerate precision diagnostics and medicine for women’s health

SiliconANGLE 1 month ago 52

Evvy, a women’s health AI startup, closed a $40 million Series B to scale its precision diagnostics and care platform. The company says it reported successfully diagnosing more than 90% of symptomatic patients and cut recurrence of conditions like bacterial vaginosis by 50%. It will use the funding to validate new AI-enabled diagnostic and care models, starting with fertility-focused care.

Heart of the Matter: How a Major Children’s Hospital Uses Open Source NVIDIA AI for Cardiac Care

NVIDIA Blog 1 month ago 36

Children’s Hospital of Philadelphia built an open-source AI cardiac modeling workflow that turns pediatric heart imaging into patient-specific 3D models for congenital heart disease planning. It cuts model creation from about four hours of researcher work to seconds. The hospital is now expanding from routine pre-op modeling to near-real-time physics simulations using NVIDIA Warp and Newton within broader clinical workflows across disciplines.

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.